Douglas C. Bates
Fondateur chez Cyprotex US LLC
Postes actifs de Douglas C. Bates
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cyprotex US LLC
 Cyprotex US LLC Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex US LLC is a company that provides contract research services specializing in preclinical ADME and Toxicology assessment. The company is based in Watertown, MA. Cyprotex US was acquired by Cyprotex Ltd., part of Evotec SE from December 15, 2016 on August 06, 2010 for $4.22 million. The company was founded by Douglas C. Bates, Katherine Tsaioun. | Fondateur | 03/12/2010 | - |
| Corporate Officer/Principal | 03/12/2010 | - |
Historique de carrière de Douglas C. Bates
Anciens postes connus de Douglas C. Bates
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CYPROTEX PLC | Directeur/Membre du Conseil | 06/08/2010 | 29/09/2011 |
| Sales & Marketing | 03/12/2010 | 29/09/2011 |
Formation de Douglas C. Bates
| Dartmouth College | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
| University of Pennsylvania | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Sales & Marketing | 1 |
| Founder | 1 |
Sectorielle
| Consumer Services | 4 |
| Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cyprotex Ltd.
 Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |
Cyprotex US LLC
Cyprotex US LLC Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex US LLC is a company that provides contract research services specializing in preclinical ADME and Toxicology assessment. The company is based in Watertown, MA. Cyprotex US was acquired by Cyprotex Ltd., part of Evotec SE from December 15, 2016 on August 06, 2010 for $4.22 million. The company was founded by Douglas C. Bates, Katherine Tsaioun. | Commercial Services |
- Bourse
- Insiders
- Douglas C. Bates
- Expérience
